Influenza Vaccines
Mostrando 1-12 de 184 artigos, teses e dissertações.
-
1. A vacina contra gripe pode provocar resultado positivo em testes para HIV em pessoas não infectadas pelo vírus?
A vacina contra gripe pode ocasionar resultados falso-positivos transitórios para HIV em pessoas não infectadas pelo vírus.
Por essa razão, se possível, pessoas que foram vacinadas e que necessitam realizar teste rápido ou laboratorial para HIV devem ser orientadas a adiar a realização do teste por pelo menos 30 dias após a realização da
Núcleo de Telessaúde Rio Grande do Sul. Publicado em: 12/06/2023
-
2. Como deve ser o esquema de imunizações em puérperas?
As vacinas recomendas a todas as gestantes são
:
A vacina dTpa é suficiente para proteção contra o tétano neonatal e difteria em gestantes com história prévia de vacinação de dupla toxóide tetânico e difteria (dT) completa (3 doses) ou que tenham recebido duas doses de dT previamente. Em casos de vacinação incompleta, com apenas u
Núcleo de Telessaúde Rio Grande do Sul. Publicado em: 12/06/2023
-
3. Influenza A and B in a cohort of outpatient children and adolescent with influenza like-illness during two consecutive influenza seasons
ABSTRACT Introduction Influenza is an important cause of morbimortality worldwide. Although people at the extremes of age have a greater risk of complications, influenza has been more frequently investigated in the elderly than in children, and inpatients than outpatients. Yearly vaccination with trivalent or quadrivalent vaccines is the main strategy to co
Braz J Infect Dis. Publicado em: 2020-02
-
4. Clinical and epidemiological aspects of microcephaly in the state of Piauí, northeastern Brazil, 2015-20166
Resumo Objetivos: Descrever os aspectos da epidemia de microcefalia no Estado do Piauí. Métodos: Foram incluídos todos os casos de microcefalia congênita confirmados no estado entre 2015-2016 (n = 100). Os formulários de investigação do Centro Regional de Referência em Microcefalia foram analisados. Os casos descartados (n = 63) foram usados como g
J. Pediatr. (Rio J.). Publicado em: 12/09/2019
-
5. IMMUNIZATION STATUS OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE
RESUMO CONTEXTO: No tratamento de doenças inflamatórias intestinais (DII) são usados imunossupressores e agentes biológicos, o que aumenta o risco de infecções pela alteração da imunidade celular e humoral. A prevenção de algumas dessas infecções pode ser feita pela vacinação, entretanto pacientes com DII apresentam baixas taxas de cobertura
Arq. Gastroenterol.. Publicado em: 26/08/2019
-
6. Safety assessment of seasonal trivalent influenza vaccine produced by Instituto Butantan from 2013 to 2017
ABSTRACT Vaccination has been a successful strategy in influenza prevention. However, despite the safety and efficacy of the vaccines, they can cause adverse events following immunization (AEFI). Moreover, due to the vaccination success, most of vaccine-preventable diseases (VPD) have become rare, and public attention has been shifted from VPD to the AEFI as
Rev. Inst. Med. trop. S. Paulo. Publicado em: 20/12/2018
-
7. Prospective cohort studies to evaluate the safety and immunogenicity of the 2013, 2014, and 2015 seasonal influenza vaccines produced by Instituto Butantan
ABSTRACT Annual vaccination is the most effective way to prevent seasonal influenza illness. Instituto Butantan (IB) performed clinical studies with its 2013, 2014 and 2015 seasonal trivalent influenza vaccines (inactivated split-virion). Prospective cohort studies were carried out to describe the safety and immunogenicity of Instituto Butantan influenza vac
Rev. Inst. Med. trop. S. Paulo. Publicado em: 30/07/2018
-
8. Evolution of equine influenza viruses (H3N8) during a Brazilian outbreak, 2015
Abstract Equine influenza is one of the major respiratory infectious diseases in horses. An equine influenza virus outbreak was identified in vaccinated and unvaccinated horses in a veterinary school hospital in São Paulo, SP, Brazil, in September 2015. The twelve equine influenza viruses isolated belonged to Florida Clade 1. The hemagglutinin and neuramini
Braz. J. Microbiol.. Publicado em: 2018-06
-
9. Cost-utility of quadrivalent versus trivalent influenza vaccine in Brazil – comparison of outcomes from different static model types
ABSTRACT Background: Influenza burden in Brazil is considerable with 4.2–6.4 million cases in 2008 and influenza-like-illness responsible for 16.9% of hospitalizations. Cost-effectiveness of influenza vaccination may be assessed by different types of models, with limitations due to data availability, assumptions, and modelling approach. Objective: To und
Braz J Infect Dis. Publicado em: 2018-01
-
10. Immunogenicity and safety of Southern Hemisphere inactivated quadrivalent influenza vaccine: a Phase III, open-label study of adults in Brazil
Abstract The World Health Organization influenza forecast now includes an influenza B strain from each of the influenza B lineages (B/Yamagata and B/Victoria) for inclusion in seasonal influenza vaccines. Traditional trivalent influenza vaccines include an influenza B strain from one lineage, but because two influenza B lineages frequently co-circulate, the
Braz J Infect Dis. Publicado em: 2017-02
-
11. La articulación público-privada en la producción de vacunas en México
ABSTRACT This paper analyzes the process of privatization of health care services through the Public-Private Articulation (APA). The production of vaccines in Mexico is studied, through the case study of Biological and Reagents Laboratories of Mexico, LLC (Birmex), company responsible for the production, distribution and investigation of biological and reage
Saúde debate. Publicado em: 2016-12
-
12. Surveillance of antiviral resistance markers in Argentina: detection of E119V neuraminidase mutation in a post-treatment immunocompromised patient
Although vaccines are the best means of protection against influenza, neuraminidase inhibitors are currently the main antiviral treatment available to control severe influenza cases. One of the most frequent substitutions in the neuraminidase (NA) protein of influenza A(H3N2) viruses during or soon after oseltamivir administration is E119V mutation. We descr
Mem. Inst. Oswaldo Cruz. Publicado em: 16/11/2016